12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca, Cancer Research UK deal

AstraZeneca and Cancer Research UK's Cancer Research Technology commercialization arm extended their 2010 cancer metabolism deal by two years to early 2015. The partners formed the original three-year alliance...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >